Literature DB >> 21299364

Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.

Irma Koivula1, Sari Hämäläinen, Esa Jantunen, Kari Pulkki, Taru Kuittinen, Tapio Nousiainen, Auni Juutilainen.   

Abstract

OBJECTIVE: To compare semi-quantitative procalcitonin with C-reactive protein in predicting bacteraemia in haematological patients with neutropenic fever.
METHODS: A total of 77 patients treated with intensive chemotherapy for haematological malignancy at Kuopio University Hospital were candidates for study entry. Eleven of these patients did not fulfil the criteria for neutropenic fever, and 66 patients were finally included. Nineteen patients had acute myeloid leukaemia and 47 had received high-dose chemotherapy supported by autologous stem cell transplant. Ninety neutropenic fever episodes in these 66 patients fulfilled the study entry criteria, with microbiological cultures, procalcitonin and C-reactive protein measurements available. Serum procalcitonin and C-reactive protein were analyzed at the onset of each neutropenic fever episode on day 0, and then daily from days 1 to 4.
RESULTS: Bacteraemia was observed in 21 episodes (23%) and the criteria for severe sepsis were fulfilled in 13 episodes (14%). Half of the bacteraemic episodes were caused by Gram-negative bacteria. The kinetics of procalcitonin and C-reactive protein were similar, with increasing levels for 2 to 4 days after the onset of fever. The procalcitonin level on days 1, 2, 3 and 4 was associated with bacteraemia and Gram-negative bacteraemia, but not with the development of severe sepsis. On day 1, a procalcitonin level above 0.5 ng/ml had a sensitivity of 57% and 70% and specificity of 81% and 77% to predict bacteraemia and Gram-negative bacteraemia, respectively.
CONCLUSIONS: An elevated level of procalcitonin within 24 h after the onset of neutropenic fever predicts bacteraemia and Gram-negative bacteraemia in haematological patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21299364     DOI: 10.3109/00365548.2011.554855

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  18 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  Procalcitonin as a Predictive Marker for Bacteremia in Children With a Central Line and Fever.

Authors:  Jennifer Damman; Patricio Arias; John Kerner; Ke-You Zhang; Melody Dehghan; Gomathi Krishnan; Colleen Nespor; Rachel Bensen; K T Park
Journal:  Hosp Pediatr       Date:  2019-06

4.  Diagnostic role of procalcitonin in patients with suspected appendicitis.

Authors:  Jiunn-Yih Wu; Hang-Cheng Chen; Si-Huei Lee; Rai-Chi Chan; Chien-Chang Lee; Shy-Shin Chang
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 5.  Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Authors:  Werner C Albrich; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2015-07-21       Impact factor: 17.440

6.  Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.

Authors:  H H Liu; M W Zhang; J B Guo; J Li; L Su
Journal:  Ir J Med Sci       Date:  2016-05-02       Impact factor: 1.568

7.  Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury.

Authors:  Biqiong Ren; Guoying Zou; Yiran Huang; Guofeng Xu; Fei Xu; Junyu He; Haowen Zhu; Ping Yu
Journal:  Cell Stress Chaperones       Date:  2016-05-02       Impact factor: 3.667

8.  Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

Authors:  Ramila Shilpakar; Bishnu Dutta Paudel; Prakash Neupane; Aarati Shah; Bibek Acharya; Soniya Dulal; Lori Anne Wood; Rukmani Shahi; Usha Khanal; Bishesh Sharma Poudyal
Journal:  J Glob Oncol       Date:  2019-09

9.  Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Authors:  Amanda G Blouin; Meier Hsu; Martin Fleisher; Lakshmi V Ramanathan; Stephen M Pastores
Journal:  Clin Chim Acta       Date:  2020-07-15       Impact factor: 3.786

10.  Evaluation of vitreous Procalcitonin as a diagnostic biomarker in infectious endophthalmitis.

Authors:  Poonam Naik; Gagan Satyashree; Ashik Mohamed; Taraprasad Das; Vivek Pravin Dave; Joveeta Joseph
Journal:  Int Ophthalmol       Date:  2021-05-24       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.